1 citations
,
April 2012 in “Korean Journal of Food Science and Technology” This study found that combining an oral herbal composition with a topical hair tonic resulted in a stronger hair growth effect in mice than either treatment alone.
1 citations
,
December 2010 in “InnovAiT” This article reviews common causes of hair loss and hair excess and discusses their management in primary care settings, but it reports no new clinical results.
1 citations
,
December 2007 in “Drug and therapeutics bulletin” This review discusses updated guidance on treating scalp ringworm in children, emphasizing newer antifungal drugs, but does not report new clinical results.
1 citations
,
May 2002 in “Therapeutische Umschau” This review discusses common hair diseases in children, highlighting diagnostic tools and treatments, but reports no new clinical results.
1 citations
,
October 2000 in “Pediatrics in Review” The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.
1 citations
,
April 1992 in “PubMed” This review discusses the clinical features of various types of hair loss, including both common and less common alopecias, and reports no new clinical results.
1 citations
,
August 1946 in “Archives of dermatology” This case presentation describes an adult with tinea capitis and related symptoms who was found to have a Trichophyton gypseum infection.
February 2026 in “International Journal of Homoeopathic Sciences” This paper reviews plica polonica, a rare hair disorder linked historically to poor hygiene and now to severe self-neglect or medical conditions, and outlines various treatment and preventive strategies but reports no new findings.
January 2026 in “Supportive Care in Cancer” This narrative systematic review reports that gel-based, cryogel, and silicone-based cooling caps offer cost-effective and environmentally sustainable alternatives to traditional machine-operated systems for preventing chemotherapy-induced hair loss, particularly benefiting low-income and low-resource settings.
November 2025 in “Revista Políticas Públicas & Cidades” In this case study, the combination of microneedling and intradermal therapy was observed to effectively stimulate hair growth and improve hair density in a menopausal woman with androgenetic alopecia, resulting in enhanced self-esteem and cosmetic satisfaction.
December 2024 in “Dermatologic Surgery” This study observed that pooled analysis of LED caps increased hair density in patients with androgenetic alopecia compared to sham, achieving 28.5 more hairs per cm².
September 2024 in “Journal of the American Academy of Dermatology” This study reports that cancer patients experiencing chemotherapy-induced alopecia actively engage in Facebook groups for support, instructions, and product recommendations related to scalp cooling, but only 5% consult dermatologists for hair loss concerns, highlighting the platform's influence on patient treatment decisions.
February 2024 in “Journal of Modern Oncology” In this study, researchers found that using the Orbis II scalp cooling device in a single-center setting effectively prevented severe chemotherapy-induced alopecia in 73% of patients with various cancer types, though the authors recommend further studies to explore broader applicability and influencing factors.
October 2023 in “International journal of women’s dermatology” This study observed that while hair camouflage techniques can boost confidence and reduce stigma for Black women with alopecia, they can also contribute to further hair damage; clinicians should consider safer styling practices as part of individualized care strategies.
November 2018 in “Annals of oncology” This study found that the computer-controlled RV-01 scalp cooling device helped prevent significant hair loss in metastatic breast cancer patients treated with eribulin, with none of the 16 patients requiring a wig and experiencing minimal discomfort.
May 2015 in “Cancer research” This study found that persistent significant alopecia was a common side effect following FEC-docetaxel chemotherapy, with a 33.4% global incidence, highlighting the need for awareness and potential preventative measures like cooling caps during treatment.
January 2004 in “Linchuang pifuke zazhi” This case report describes a young man who suffered from secondary cicatrical alopecia due to a steam cap burn at a hair salon, with no improvement after 13 months of various treatments until surgical excision.
This article provides physician associates with an evidence-based approach to diagnosing and treating alopecia, focusing on recognizing patterns, identifying triggers, and applying targeted interventions to improve patient outcomes in hair loss.
August 2026 in “Frontiers in Nutrition” This study reports that combining ergothioneine, collagen peptides, and sodium hyaluronate improved skin parameters like hydration, elasticity, and wrinkle reduction in Chinese women, while ex vivo data indicated enhanced antioxidant action and structural support, suggesting potential for anti-aging nutricosmetics.
August 2026 in “International Journal of Bioprinting” This review highlights the complexities of hair graying and the limitations of current models to fully replicate hair follicle pigmentary unit function, suggesting that technologies like organoids and bioprinting show promise but require further development for effective hair repigmentation interventions.
August 2026 in “Non-coding RNA Research” The study reports that vitamin E improves hair-follicle growth and dermal papilla cell proliferation in vitro by modulating the lncRNA2919/STAT1/SHH axis in Angora rabbits, enhancing cellular antioxidant capacity.
August 2026 in “Journal of Personalized Medicine” This narrative review proposes the concept of "repigmentation competence" for vitiligo lesions, suggesting that therapy responses are influenced by lesion-specific biological factors related to immune, regenerative, regulatory, and microenvironmental processes, and highlights the emerging role of combination therapies targeting these pathways.
August 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This narrative review suggests that the association between weight-loss medications and telogen effluvium is primarily due to metabolic changes from rapid weight loss, rather than a direct pharmacological effect on hair follicles.
July 2026 in “Dermatology Practical & Conceptual” In this study, pediatric hair and scalp disorders were effectively diagnosed using trichoscopic and light microscopic examinations, demonstrating high agreement with clinical diagnoses and emphasizing their utility as reliable, non-invasive diagnostic tools in a hospital-based setting.
In this study, trichoscopy was diagnostically useful in 97.5% of alopecia cases at a rural Indian hospital, confirming initial diagnoses in most cases and reducing the need for invasive scalp biopsies.
July 2026 in “Journal of Investigative Dermatology” More research is needed to understand hair and scalp disorders in children with skin of color.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers developed a hybrid deep learning model called ScalpViT that accurately diagnosed scalp diseases with 94.3% accuracy, surpassing existing methods like ResNet-50 and EfficientNet-B3, and providing visual explainability for clinicians using GradCAM and Attention Rollout techniques.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study introduces ScalpViT, a new deep learning model that accurately diagnoses visually similar scalp diseases with 94.3% accuracy, outperforming other methods like ResNet-50 and EfficientNet-B3, and providing dual visual explainability through GradCAM and Attention Rollout, potentially benefiting diagnosis in resource-limited settings in India.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, researchers developed ScalpViT, a novel deep learning model, to improve the automated diagnosis of visually similar scalp diseases, achieving 94.3% accuracy and outperforming existing models like ResNet-50 and EfficientNet-B3 when tested on a diverse dataset of 7,000 images.
May 2026 in “Journal of Medicinal Food” This study found that orally administered hydrolyzed keratin peptide promoted hair growth and enhanced cellular proliferation and antioxidant capacity in mice and human cell models, suggesting its potential as a functional food ingredient for hair health.